-       Report 
- August 2023
-  85 Pages 
- United States 
   From       €4338EUR$4,850USD£3,816GBP 
          -       Report 
- August 2023
-  63 Pages 
- Vietnam 
   From       €1784EUR$1,995USD£1,570GBP 
          -       Report 
- July 2023
-  80 Pages 
- Global 
   From       €4338EUR$4,850USD£3,816GBP 
          -       Report 
- July 2023
-  210 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- June 2023
-  56 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
           -       Training 
- June 2023
-  2 Days 
- Global 
   From       €1318EUR$1,474USD£1,159GBP 
          -       Report 
- June 2023
-  180 Pages 
- Global 
   From       €3354EUR$3,750USD£2,950GBP 
          -       Training 
- March 2023
-  2 Days 
- Global 
   From       €1648EUR$1,843USD£1,450GBP 
          -       Report 
- February 2023
- Global 
        €4990EUR$5,976USD£4,543GBP 
          -       Report 
- January 2023
-  28 Pages 
- Global 
   From       €1208EUR$1,350USD£1,062GBP 
          -       Report 
- December 2022
-  140 Pages 
- Global 
        €10733EUR$12,000USD£9,441GBP 
          -       Report 
- November 2022
-  150 Pages 
- Global 
   From       €4338EUR$4,850USD£3,816GBP 
          -       Report 
- November 2022
-  160 Pages 
- Global 
        €3041EUR$3,400USD£2,675GBP 
          -       Report 
- November 2022
-  220 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- November 2022
-  220 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- September 2022
-  40 Pages 
- Global 
             -       Report 
- September 2022
-  95 Pages 
- Global 
   From       €3801EUR$4,250USD£3,344GBP 
          -       Report 
- May 2022
-  117 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- April 2022
- Global 
        €8945EUR$10,000USD£7,868GBP 
          -       Report 
- April 2022
- Global 
        €7156EUR$8,000USD£6,294GBP 
       
       The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically    more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less   Read more